KC-5816

Ba/F3-mCRBN-humanized-KI-Plus Cell Line

×
Please enable JavaScript in your browser to complete this form.
60213
Home » Ba/F3-mCRBN-humanized-KI-Plus Cell Line

Background of Ba/F3-mCRBN-humanized-KI-Plus Cell Line

The Ba/F3-mCRBN-humanized-KI cell line is generated by introducing specific humanizing point mutations into the endogenous mouse Crbn locus. This model is designed to support targeted protein degradation research, particularly the high-throughput screening of molecular glue degraders and the investigation of their mechanisms of action. By humanizing CRBN, the cell line recapitulates human-specific drug responses within a murine cellular context. A key advantage of this system is the combination of human-like pharmacological activity with the experimental versatility of Ba/F3 cells. The Ba/F3 background offers ease of genetic manipulation and robust proliferation, facilitating large-scale screening assays. Meanwhile, humanized CRBN expression ensures clinically relevant readouts, improving the translational predictive value of preclinical findings in targeted degradation therapy development.

Specifications

Catalog NumberKC-5816
Cell Line NameBa/F3-mCRBN-humanized-KI-Plus Cell Line
NCBI/UniProt Accession Number58799/Q8C7D2
Clone Number2A4
Host Cell LineBa/F3
DescriptionIn Ba/F3 cells, the endogenous mouse CRBN gene was replaced with the human CRBN coding sequence under the control of an exogenous promoter.
QuantityTwo vials of frozen cells (≥2-106/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% RPMI1640 + 20% FBS + 10% DMSO
Propagation MediumRPMI1640+10% FBS+8 ng/mL mouse IL-3
Selection MarkerNA
MorphologyMostly single, round (some polymorph) cells in suspension
SubcultureSplit saturated culture 1:10 every 3 days; seed out at about 1-3 × 105 cells/mL
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 20 hours
Mycoplasma StatusNegative

Cell Line Generation

Ba/F3-mCRBN-humanized-KI-Plus cell line was generated using the CRISPR method.

Characterization

Figure 1: Characterization of Ba/F3-mCRBN-humanized-KI cell line stable clone using PCR sequencing.

Figure 2: Characterization of Ba/F3-mCRBN-humanized-KI cell line stable clone using western blot.

Cell Resuscitation

  1. Prewarm culture medium (RPMI1640+10% FBS+8 ng/mL mouse IL-3) in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:10 every 3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% RPMI1640 + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage.

References

  1. Naruse C, Ishibashi O, Asano M, et al. Differential substrate degradation by super-degron: EGFP in wild-type mouse cells, PD-1 requires CRBN humanization. iScience. 2025; 28(7): 112992. doi: 10.1016/j.isci.2025.112992.
  2. Li SR, Fu J, Wang H, et al. IMiD compounds affect CD34+ cell fate and maturation via CRBN-induced IKZF1 degradation. Blood Adv. 2018;2(5):492–504. doi:10.1182/bloodadvances.2017010348. PMID:29606568; PMCID:PMC5876033.
Please enable JavaScript in your browser to complete this form.